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ated and the number of CD4+-lym-
phocytes increases rapidly due to it, 
then there is an excessive stimulation 
of their activity by cytokines secreted 
by infected macrophages. As a result, 
there is an overwhelming increase in 
concentration of T-helper-1 proin-
flammatory cytokines, such as IFN-γ, 
IL-2 and IL-12. The next chain is in-
creased synthesis of proinflamma-
tory IL-6 and TNF-α by macrophages 
which leads to the appearance of new 
or progression of existing pathomor-
phological and clinical manifestations 
of tuberculosis.
Thus, T-helpers play a key role 
in the pathogenesis of IRIS. How-
ever, there are probably additional 
factors that influence the formation 
of an excessive inflammatory re-
sponse to TB infection. This opinion 
is prompted by the fact that in some 
patients IRIS develops before a sig-
nificant increase in the number of T-
lymphocytes in the peripheral blood. 
Such situations are thought to be as-
sociated with a local cell-mediated 
immune response involving CD4+-
lymphocytes. 
Conclusions. The immuno-
pathogenesis of immune reconsti-
tution inflammatory syndrome is 
based on a sharp increase in the 
number of T-helpers against the 
background of opportunistic infec-
tion in the body with subsequent ex-
cessive activation of macrophages 
and the synthesis of a large amount 
of pro-inflammatory cytokines with 
corresponding pathomorphological 
changes. 
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Introduction
The problem of tuberculosis in 
patients with diabetes mellitus (DM) 
has received increasing attention in 
recent years. Increased interest is 
due, on the one hand, to an increase 
in the number of tuberculosis pa-
tients with multiple drug resistance 
of the pathogen, and on the other - a 
steady increase in the prevalence of 
diabetes in Europe.
Materials and methods. A ret-
rospective analysis of 1687 medical 
records was carried out, that were 
listed in the registry database of 
Chernivtsi Regional Clinical TB Dis-
pensary.
Results and discussion.
Having conducted a retrospec-
tive study, the polymorobicity of TB 
/ DM was  found in 6.6% of cases 
which slightly differs from the index 
that co-researchers had found, that 
was 6.3%. In the following diagram 
the frequency of comorbid TB / 
DM disease in Chernivtsi region is 
shown. The results rather indicate 
on increase in the proportion of 
diabetes mellitus in the population 
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than the increase of tuberculosis in-
fection. 
From a gender perspective, 
there are more men in the examined 
sample which is statistically a com-
mon occurrence for patients with TB. 
According to age distribution, there 
were more middle-aged and elderly 
people in both samples, comorbidity 
of TB and diabetes,however,was def-
initely more common among people 
over 45 years old (the difference was 
3.9 times, p=0.05). 
According to the results of our 
research presented on the slide, 
diabetes is registered in 16.9% of 
TB cases with diagnosed poli- and 
comorbidity. It was discovered that 
common types of tuberculosis are 
definitely more often diagnosed 
in the examined group of patients 
(58% – disseminated clinical type). 
In the sample of TB/diabetes 
comorbidity, type 2 diabetes, 
diagnosed in 81.4% of cases, 
prevailed. 
Conclusions
To sum it up, according to the re-
sults of our research, the prevalence 
of TB/diabetes comorbidity consti-
tutes 6.7% in the general sample. 
Comorbidity of TB/diabetes prevails 
among males (79.9%) aged between 
45 and 70 and in more than half the 
cases is characterized by the dis-
seminated clinical form (58%). Drug-
susceptible TB constitutes 86%, 
multiresistant – 7.2%, drug resistant 
tuberculosis divided according to the 
resistance profile: 3.4% – monore-
sistant and 3.4% – poliresistant tu-
berculosis. 




Харківський національний медичний 
університет
Діагностика медикаментозної 
алергії (МА) являє достатньо ве-
лику складність, що обумовлено 
як самою структурою лікарських 
алергенів, так і різними варіантами 
імунної відповіді на ліки. Згідно з 
Міжнародним Консенсусом по ме-
дикаментозній аллергії (Iternational 
Consensus on drug allergy) реакції 
на ліки, за клінічними ознаками, які 
нагадують алергію, рекомендуєть-
ся позначати терміном «реакції лі-
карської гіперчутливості» (РЛГ). У 
той час як «медикаментозна алер-
гія» – це РЛГ, для якої продемон-
стрований певний імунологічний 
механізм.
Головним патогенетичним ме-
ханізмом АР на лікарські засоби 
(ЛЗ) є змінена імунна реактивність, 
яка проявляється у  гіперпродукції 
специфічних антитіл, частіше IgE, 
рідше IgG4, специфічно сенсибілі-
зованими В-лімфоцитами, проза-
пальних цитокінів та інших медіа-
торів, таких як преформовані (гіс-
тамін, тріптаза, гепарин, хімаза, 
хемоаттрактанти), так і вторинних 
(цістеінові лейкотрієни, проста-
гландини, тромбоксани, фактор, 
який активує тромбоцити, браді-
кін). 
При пошуку «винного» алер-
гену анамнез є визначальним. Ха-
рактерний зв›язок клінічних симп-
